JAIMIE TERRASI: Open Payments
NPI 1124610753 · TOLEDO, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,720 in 96 payments from 16 companies in 2025. Trend: 2023 $1,449 · 2024 $1,442 · 2025 $1,720
Food & beverage: $1,714Education: $6
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 33 | $345 |
| Bayer Healthcare Pharmaceuticals Inc. | 11 | $244 |
| Travere Therapeutics, Inc. | 9 | $203 |
| Ardelyx, Inc. | 9 | $200 |
| Amgen Inc. | 8 | $140 |
| Calliditas Therapeutics US Inc. | 4 | $128 |
| Novo Nordisk Inc | 3 | $65 |
| AKEBIA THERAPEUTICS INC | 3 | $65 |
| Fresenius USA Marketing, Inc. | 3 | $65 |
| AstraZeneca Pharmaceuticals LP | 4 | $63 |
Products named: JYNARQUE, Kerendia, IBSRELA, TARPEYO, KRYSTEXXA, Ozempic, Vafseo, VELPHORO.
Industry payments across OH — which companies pay providers there.
